WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis
Proceedings of the National Academy of Sciences · 28.03.2023 · 120 (13)
DOI: 10.1073/pnas.2219956120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.03.2023. Verfasst von Stephen T Ferris und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Islets of Langerhans. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The events that initiate autoimmune diabetes in nonobese diabetic (NOD) mice remain poorly understood. CD4 + and CD8 + T cells are both required to develop disease, but their relative roles in initiating disease are unclear. To test whether CD4 + T cell infiltration into islets requires damage to β cells induced by autoreactive CD8 + T cells, we inactivated Wdfy4 in nonobese diabetic (NOD) mice (NOD. Wdfy4 −/−- ) using CRISPR/Cas9 targeting to eliminate cross-presentation by type 1 conventional dendritic cells (cDC1s). Similar to C57BL/6 Wdfy4 −/− mice, cDC1 in NOD. Wdfy4 −/− mice are unable to cross-present cell-associated antigens to prime CD8 + T cells, while cDC1 from heterozygous NOD. Wdfy4 +/− mice cross-present normally. Further, NOD. Wdfy4 −/− mice fail to develop diabetes while heterozygous NOD. Wdfy4 +/− mice develop diabetes similarly to wild-type NOD mice. NOD. Wdfy4 −/− mice remain capable of processing and presenting major histocompatibility complex class II (MHC-II)-restricted autoantigens and can activate β cell-specific CD4 + T cells in lymph nodes. However, disease in these mice does not progress beyond peri-islet inflammation. These results indicate that the priming of autoreactive CD8 + T cells in NOD mice requires cross-presentation by cDC1. Further, autoreactive CD8 + T cells appear to be required not only to develop diabetes, but to recruit autoreactive CD4 + T cells into islets of NOD mice, perhaps in response to progressive β cell damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Immunology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
ORCID-Profile: Tiantian Liu
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Ferris, S. T., Liu, T., Chen, J., Ohara, R. A., Ou, F., Wu, R., Kim, S., Murphy, T. L., & Murphy, K. M. (2023). WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis. Proceedings of the National Academy of Sciences, 120(13). https://doi.org/10.1073/pnas.2219956120
Vancouver
Ferris ST, Liu T, Chen J, Ohara RA, Ou F, Wu R, et al. WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis. Proceedings of the National Academy of Sciences. 2023;120(13). doi:10.1073/pnas.2219956120
BibTeX
@article{Ferris2023,
author = {Ferris, Stephen T and Liu, Tiantian and Chen, Jing and Ohara, Ray A and Ou, Feiya and Wu, Renee and Kim, Sunkyung and Murphy, Theresa L and Murphy, Kenneth M},
title = {WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {13},
doi = {10.1073/pnas.2219956120}
}
EUVIMED